Entry price: 141.13
Fundamentals:
- Sector: Medical - Research
- EPS % Chg (Last Qtr): 97%
- EPS % Chg (Previous Qtr): 57%
- 3 Year EPS Growth Rate: 22%
- EPS Est % Chg (Current Yr): 75%
- Sales % Chg (Last Qtr): 36%
- Sales % Chg (Previous Qtr): 12%
- 3-Year Sales Growth Rate: 12%
- Annual Pre -Tax Margin: 18.4%